87 related articles for article (PubMed ID: 34737552)
21. Thermogel Delivers Oxaliplatin and Alendronate
Sun Y; Li K; Li C; Zhang Y; Zhao D
Front Bioeng Biotechnol; 2020; 8():573962. PubMed ID: 33042974
[TBL] [Abstract][Full Text] [Related]
22. Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent.
Jerez HE; Simioni YR; Ghosal K; Morilla MJ; Romero EL
Beilstein J Nanotechnol; 2024; 15():517-534. PubMed ID: 38774586
[TBL] [Abstract][Full Text] [Related]
23. A Drug Delivery System for Administration of Anti-TNF-α Antibody.
Robert MC; Frenette M; Zhou C; Yan Y; Chodosh J; Jakobiec FA; Stagner AM; Vavvas D; Dohlman CH; Paschalis EI
Transl Vis Sci Technol; 2016 Mar; 5(2):11. PubMed ID: 26981333
[TBL] [Abstract][Full Text] [Related]
24. Metal-based nano-delivery platform for treating bone disease and regeneration.
Liu Y; Xu Z; Qiao M; Cai H; Zhu Z
Front Chem; 2022; 10():955993. PubMed ID: 36017162
[TBL] [Abstract][Full Text] [Related]
25. Encapsulation, Release, and Cytotoxicity of Doxorubicin Loaded in Liposomes, Micelles, and Metal-Organic Frameworks: A Review.
Ibrahim M; Abuwatfa WH; Awad NS; Sabouni R; Husseini GA
Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213987
[TBL] [Abstract][Full Text] [Related]
26. Research progress of bone-targeted drug delivery system on metastatic bone tumors.
Hu B; Zhang Y; Zhang G; Li Z; Jing Y; Yao J; Sun S
J Control Release; 2022 Oct; 350():377-388. PubMed ID: 36007681
[TBL] [Abstract][Full Text] [Related]
27. Glycopolymer-Functionalized MOF-808 Nanoparticles as a Cancer-Targeted Dual Drug Delivery System for Carboplatin and Floxuridine.
Demir Duman F; Monaco A; Foulkes R; Becer CR; Forgan RS
ACS Appl Nano Mater; 2022 Oct; 5(10):13862-13873. PubMed ID: 36338327
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of Cancer Chemotherapeutic Efficacy via Bone-Targeted Drug Delivery Carrier in Bone Metastases.
Xue X; Yu J; Lu F; Jiang H; Wang X
Drug Des Devel Ther; 2021; 15():4455-4468. PubMed ID: 34737552
[TBL] [Abstract][Full Text] [Related]
29. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
[TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.
Ye WL; Zhao YP; Li HQ; Na R; Li F; Mei QB; Zhao MG; Zhou SY
Sci Rep; 2015 Sep; 5():14614. PubMed ID: 26419507
[TBL] [Abstract][Full Text] [Related]
31. Actively targeted delivery of doxorubicin to bone metastases by a pH-sensitive conjugation.
Ye WL; Zhao YP; Na R; Li F; Mei QB; Zhao MG; Zhou SY
J Pharm Sci; 2015 Jul; 104(7):2293-303. PubMed ID: 25980534
[TBL] [Abstract][Full Text] [Related]
32. Ligand-Modified Erythrocyte Membrane-Cloaked Metal-Organic Framework Nanoparticles for Targeted Antitumor Therapy.
Lin Y; Zhong Y; Chen Y; Li L; Chen G; Zhang J; Li P; Zhou C; Sun Y; Ma Y; Xie Z; Liao Q
Mol Pharm; 2020 Sep; 17(9):3328-3341. PubMed ID: 32804508
[TBL] [Abstract][Full Text] [Related]
33. Calcium phosphate nanoparticles functionalized with alendronate-conjugated polyethylene glycol (PEG) for the treatment of bone metastasis.
Chu W; Huang Y; Yang C; Liao Y; Zhang X; Yan M; Cui S; Zhao C
Int J Pharm; 2017 Jan; 516(1-2):352-363. PubMed ID: 27887884
[TBL] [Abstract][Full Text] [Related]
34. Bone metastases: a comprehensive review of the literature.
Migliorini F; Maffulli N; Trivellas A; Eschweiler J; Tingart M; Driessen A
Mol Biol Rep; 2020 Aug; 47(8):6337-6345. PubMed ID: 32749632
[TBL] [Abstract][Full Text] [Related]
35. Basic and clinical associations between bone and cancer.
He F; Matsumoto Y
Immunol Med; 2020 Sep; 43(3):103-106. PubMed ID: 32301686
[TBL] [Abstract][Full Text] [Related]
36. Rhein-PEG-nHA conjugate as a bone targeted drug delivery vehicle for enhanced cancer chemoradiotherapy.
Yang X; Zhai D; Song J; Qing R; Wang B; Ji J; Chen X; Hao S
Nanomedicine; 2020 Jul; 27():102196. PubMed ID: 32272233
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
